KCM
ATRS

Kingdon Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Kingdon Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-946,987
Closed -$3.05M – 144
2017
Q2 		$3.05M Sell
946,987
-851,508
-47% -$2.41M 0.21% 78
2017
Q1 		$5.11M Sell
1,798,495
-218,335
-11% -$525K 0.28% 73
2016
Q4 		$4.7M Buy
2,016,830
+390,092
+24% +$743K 0.23% 99
2016
Q3 		$2.73M Buy
1,626,738
+347,870
+27% +$426K 0.13% 98
2016
Q2 		$1.34M Sell
1,278,868
-34,380
-3% -$33.2K 0.07% 95
2016
Q1 		$1.14M Sell
1,313,248
-710,620
-35% -$688K 0.06% 101
2015
Q4 		$2.45M Buy
2,023,868
+58,130
+3% +$80.9K 0.12% 102
2015
Q3 		$3.34M Buy
1,965,738
+300,000
+18% +$588K 0.16% 98
2015
Q2 		$3.46M Buy
1,665,738
+500,000
+43% +$1.21M 0.14% 108
2015
Q1 		$3.16M Hold
1,165,738
– – 0.13% 128
2014
Q4 		$3M Hold
1,165,738
– – 0.13% 123
2014
Q3 		$2.13M Hold
1,165,738
– – 0.1% 142
2014
Q2 		$3.1M Sell
1,165,738
-325,000
-22% -$978K 0.12% 156
2014
Q1 		$5.2M Sell
1,490,738
-313,362
-17% -$1.39M 0.27% 104
2013
Q4 		$8.06M Buy
1,804,100
+1,229,100
+214% +$5.01M 0.37% 84
2013
Q3 		$2.33M Buy
575,000
+75,000
+15% +$328K 0.11% 154
2013
Q2 		$2.06M Buy
+500,000
New +$1.93M 0.12% 165

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kingdon Capital Management's ATRS Position: Q3 2017 in Review

Kingdon Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2017, closing a stake of 946,987 shares — an estimated $3.05M sold.

Kingdon Capital Management first reported a position in ATRS in Q2 2013 and held it in 17 quarters. The position peaked at $8.06M in Q4 2013. 103 funds tracked by Wall St. Rank hold ATRS as of Q3 2017.

  • Kingdon Capital Management reported no remaining Antares Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Kingdon Capital Management sold 946,987 Antares Pharma, Inc. shares in Q3 2017, an estimated $3.05M.
  • Kingdon Capital Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 17 quarters.
  • Kingdon Capital Management's Antares Pharma, Inc. position peaked at $8.06M in Q4 2013.
  • 103 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2017.

Based on Kingdon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.